Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Change in Taxes: 2023-2024

Historic Change in Taxes for Entrada Therapeutics (TRDA) over the last 2 years, with Dec 2024 value amounting to -$3.4 million.

  • Entrada Therapeutics' Change in Taxes rose 133.33% to $620,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year decrease of 172.46%. This contributed to the annual value of -$3.4 million for FY2024, which is 183.42% down from last year.
  • Latest data reveals that Entrada Therapeutics reported Change in Taxes of -$3.4 million as of FY2024, which was down 183.42% from $4.0 million recorded in FY2023.
  • Entrada Therapeutics' 5-year Change in Taxes high stood at $4.0 million for FY2023, and its period low was -$3.4 million during FY2024.
  • In the last 2 years, Entrada Therapeutics' Change in Taxes had a median value of $333,500 in 2023 and averaged $333,500.
  • Data for Entrada Therapeutics' Change in Taxes shows a maximum YoY plummeted of 183.42% (in 2024) over the last 5 years.
  • Entrada Therapeutics' Change in Taxes (Yearly) stood at $4.0 million in 2023, then crashed by 183.42% to -$3.4 million in 2024.